Skip to main content
. 2016 Jun 20;2016:9545241. doi: 10.1155/2016/9545241

Table 4.

Association of BRCA1 promoter methylation with mitosis, immunohistochemistry, and molecular subtype of breast cancer.

Overall (N = 40) % BRCA1 methylation in normal tissues BRCA1 methylation in cancer tissues
  Methylated (14)   Unmethylated (26) p value   Methylated (17)   Unmethylated (23) p value
Freq. (%) Freq. (%) Freq. (%) Freq. (%)
Mitosis:
 0 4 10.0% 0 (0) 4 (15.4) 0.292 0 (0.0) 4 (17.4) 0.042
 1 5 12.5% 3 (21.4) 2 (7.7) 4 (23.5) 1 (4.3)
 2 29 72.5% 10 (71.4) 19 (73.1) 13 (76.5) 16 (69.6)
 3 2 5.0% 1 (7.1) 1 (3.8) 0 (0.0) 2 (8.7)
Estrogen receptor:
 Positive 27 67.5% 10 (71.4) 17 (65.4) 0.912 13 (76.5) 14 (60.9) 0.568
 Negative 7 17.5% 2 (14.3) 5 (19.2) 2 (11.8) 5 (21.7)
 No available data 6 15.0% 2 (14.3) 4 (15.4) 2 (11.8) 4 (17.4)
Progesterone receptor:
 Positive 25 62.5% 9 (64.3) 16 (61.5) 0.985 11 (64.7) 14 (60.9) 0.907
 Negative 9 22.5% 3 (21.4) 6 (23.1) 4 (23.5) 5 (21.7)
 No available data 6 15.0% 2 (14.3) 4 (15.4) 2 (11.8) 4 (17.4)
Her2:
 Positive 10 25.0% 2 (14.3) 8 (30.8) 0.279 2 (11.8) 8 (34.8) 0.007
 Negative 19 47.5% 9 (64.3) 10 (38.5) 13 (76.4) 6 (26.1)
 No available data 11 27.5% 3 (21.4) 8 (30.8) 2 (11.8) 9 (39.1)
Molecular subtype:
 Luminal A 13 32.5% 7 (50.0) 6 (23.1) 0.242 9 (52.9) 4 (17.4) 0.049
 Luminal B 9 22.5% 2 (14.3) 7 (26.9) 2 (11.8) 7 (30.4)
 Basal-like 2 5.0% 1 (7.1) 1 (3.8) 2 (11.8) 0 (0.0)
 Her2 1 2.5% 1 (7.1) 0 (0.0) 0 (0.0) 1 (4.3)
 Others 8 20.0% 1 (7.1) 7 (26.9) 2 (11.8) 6 (26.1)
 No available data 7 17.5% 2 (14.3) 5 (19.2) 2 (11.8) 5 (21.7)

Chi-square exact test is statistically significant at 95% confidence level.